Drawing for INTELLIMAMMO

USPTO serial 90295872

INTELLIMAMMO

Reviewed by CopyMark Law Group

Reg. 7043591Status 700Registered
Filing date
Status date
Registration date
May 2, 2023
Examiner
BULLOFF, TOBY ELLEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INTELLIMAMMO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey R. Cadwell

Jeffrey R. Cadwell DORSEY & WHITNEY LLP50 SOUTH SIXTH STREETSUITE 1500MINNEAPOLIS, MN 55402-1498

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; downloadable and recorded computer software for medical diagnostic imaging; downloadable and recorded computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, namely, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; downloadable and recorded computer software for processing and analysis of radiological images for medical diagnostic imaging; downloadable and recorded computer software in the field of medical diagnostic imaging for managing quality control including training; downloadable and recorded computer software, for medical diagnostic imaging using algorithms, to facilitate the comparison of metrics, medical and healthcare analytics and informatics, and data capture, and clinical decision tools; computers and tablet computers for medical use, use with x-ray machines, use for medical diagnosis, use for imaging purposes; downloadable and recorded computer software for quality control, namely, computer software for use in controlling quality of diagnostic medical images, and for providing quality assurance in medical screening for diagnostic and treatment purposes in medical screening for diagnostic and treatment purposesACTIVENov 12, 2020
042Software research, development, engineering, design, installation, creation for medical diagnostic imaging; software research, development, engineering, design, installation, creation in the fields of medicine, health, disease, pharmacology, oncology, and radiology for medical diagnostic imaging; medical technology development and research in the field of medical diagnostic imaging; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; platform as a service (PAAS) featuring computer software for medical diagnostic imaging; platform as a service (PAAS) featuring computer software platforms for medical diagnostic imaging, namely, software to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of breast density, and breast cancer; software as service (SAAS) services featuring software for use in the fields of medicine, health and disease, namely, software to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of breast density, and breast cancer; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, namely, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; software design in the field of medical diagnostic imaging; medical software design in the field of medical diagnostic imaging; research services in the fields of medicine, health care, disease, pharmacology, oncology, and radiologyACTIVENov 12, 2020
044Providing medical information to patients and medical professionals in the form of downloadable medical reports in the field of medical diagnostic imaging for patient care, regulatory compliance, and medical clinic operations, for display on computer screensACTIVENov 12, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 2, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 2, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 29, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 23, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 22, 2023IUAFUSE AMENDMENT FILED—
Mar 22, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 12, 2022EX2GSOU EXTENSION 2 GRANTED—
Oct 12, 2022EXT2SOU EXTENSION 2 FILED—
Oct 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 19, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 18, 2022EX1GSOU EXTENSION 1 GRANTED—
Apr 16, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 12, 2022EXT1SOU EXTENSION 1 FILED—
Apr 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 17, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 17, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 28, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2021FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jul 9, 2021ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 28, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2021ALIEASSIGNED TO LIE—
Apr 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2021GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 13, 2021GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 13, 2021EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Apr 13, 2021CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 8, 2021DOCKASSIGNED TO EXAMINER—
Dec 31, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance